Moreover, resveratrol was incorporated together with curcumin into immunoliposomes carrying trastuzumab, a HER2-targeted humanized monoclonal antibody approved for clinical use in breast cancer patients, and the properties of these immunoliposomes were studied in two human HER2+ breast cancer cell lines. The gene discussed is ERBB2; the disease is breast carcinoma.